Literature DB >> 16439118

The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes.

Li Xiao1, Hiroya Takada, Xue hui Gan, Nobuhiko Miwa.   

Abstract

Fullerene was entrapped in polyvinylpyrrolidone of 60-80 kDa at a molar ratio range of 0.42-0.67:1, resulting in a water-soluble derivative with a mean particle diameter of about 688 nm, named "Radical Sponge" because of its ROS-scavenging ability as previously demonstrated, and examined in the present study for its photo-biological actions toward human skin keratinocytes HaCaT. The keratinocytes were repeatedly irradiated with a visible light of wavelengths of 400-2000 nm (approximately 19,800 lux) in the presence or absence of Radical Sponge of 25-75 microM and did not exhibit any photo-cytotoxicity due to coexistent Radical Sponge as compared with the sham-irradiation control. Radical Sponge exerted a more marked cytoprotection at doses of 10-40 microM against UVA irradiation of 30 J/cm(2) when it was pre-irradiationally administered and rinsed out immediately before the irradiation, than when administered only during or after the irradiation, indicating the preventive rather than therapeutic or ray-sheltering effect of Radical Sponge on UVA injuries. Cytoprotection by Radical Sponge against UVA was achieved at the advisable range doses of 10-40 microM in contrast to no effect of polyvinylpyrrolidone alone; its dose-dependency was advantageous over that of VC-IP, a tetra-alkyl-esterized provitamin C, which became less cytoprotective above 20 microM. Thus, Radical Sponge is expected as an anti-UVA-preventive agent without visible-light-catalyzed cytotoxicity toward human skin keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439118     DOI: 10.1016/j.bmcl.2005.12.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy.

Authors:  Maciej Serda; Matthew J Ware; Jared M Newton; Sanchit Sachdeva; Martyna Krzykawska-Serda; Lam Nguyen; Justin Law; Andrew O Anderson; Steven A Curley; Lon J Wilson; Stuart J Corr
Journal:  Nanomedicine (Lond)       Date:  2018-12-03       Impact factor: 5.307

2.  Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.

Authors:  Jing Tong; Matthew C Zimmerman; Shumin Li; Xiang Yi; Robert Luxenhofer; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2011-02-20       Impact factor: 12.479

3.  Fullerenes in Biology and Medicine.

Authors:  Edison Castro; Andrea Hernandez Garcia; Gerardo Zavala; Luis Echegoyen
Journal:  J Mater Chem B       Date:  2017-07-08       Impact factor: 6.331

4.  Evaluation of extraction methods for quantification of aqueous fullerenes in urine.

Authors:  Troy M Benn; Benny F G Pycke; Pierre Herckes; Paul Westerhoff; Rolf U Halden
Journal:  Anal Bioanal Chem       Date:  2010-12-12       Impact factor: 4.142

5.  Detection of fullerenes (C60 and C70) in commercial cosmetics.

Authors:  Troy M Benn; Paul Westerhoff; Pierre Herckes
Journal:  Environ Pollut       Date:  2011-05       Impact factor: 8.071

6.  PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats.

Authors:  Achini K Vidanapathirana; Leslie C Thompson; Erin E Mann; Jillian T Odom; Nathan A Holland; Susan J Sumner; Li Han; Anita H Lewin; Timothy R Fennell; Jared M Brown; Christopher J Wingard
Journal:  Reprod Toxicol       Date:  2014-08-01       Impact factor: 3.143

Review 7.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007

8.  Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19

9.  The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials.

Authors:  Jun-Jie Yin; Fang Lao; Peter P Fu; Wayne G Wamer; Yuliang Zhao; Paul C Wang; Yang Qiu; Baoyun Sun; Gengmei Xing; Jinquan Dong; Xing-Jie Liang; Chunying Chen
Journal:  Biomaterials       Date:  2008-11-04       Impact factor: 12.479

Review 10.  Fullerenols as a new therapeutic approach in nanomedicine.

Authors:  Jacek Grebowski; Paulina Kazmierska; Anita Krokosz
Journal:  Biomed Res Int       Date:  2013-10-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.